Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in million yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the domestic business, strong performance by new products and the health food brand, together with the launch of new product lines, contributed to higher net sales. In the overseas business, the company promoted expansion into new markets, including the launch of BOTANIST at Costco in the United States and YOLU at OLIVE YOUNG in South Korea. All categories, including hair care, beauty appliances and skin care, recorded double-digit year-on-year growth.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | 26,808 million yen (YoY +20.1%) |
| Operating profit | 2,012 million yen (YoY +19.2%) |
| Ordinary income | 1,911 million yen (YoY +20.4%) |
| Profit attributable to owners of the parent | 1,047 million yen (YoY +13.5%) |
| Net income per share | ¥58.92 |
| Equity ratio | End of the current fiscal period 53.1% / End of previous period 49.8% |
| Total assets | 33,419 million yen |
| Net assets | 17,989 million yen |
| Cash flows from operating activities | 2,586 million yen |
| Cash flows from investing activities | -281 million yen |
| Cash flows from financing activities | -3,969 million yen |
| Cash and cash equivalents at end of period | 6,896 million yen |
| Full-year earnings forecast | Net Sales 55,000～57,000 / EBITDA 1,700～3,200 / Operating profit 0～1,500 / Ordinary income Not disclosed / Net income Not disclosed |
| Revision to Earnings Forecast | Net Sales Not disclosed → 55,000～57,000 / EBITDA Not disclosed → 1,700～3,200 / Operating profit Not disclosed → 0～1,500 / Ordinary income Not disclosed / Net income Not disclosed |
| Annual Dividend Forecast | 15.00 yen → 15.00 yen（0.0%） |
| Segment revenue | Domestic Business 25,818 million yen (YoY +18.7%) / Overseas Operations 989 million yen (YoY +74.6%) |
| Segment profit | Domestic Business 3,769 million yen (YoY +16.5%) / Overseas Operations -25 million yen |
| Depreciation and amortization | 553 million yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Repayment of executive compensation / Amount 4 million yen / Extraordinary loss Item Special investigation expenses and related costs / Amount 219 million yen, Item Penalty for breach of listing agreement / Amount 33 million yen, Item Levy / Amount 6 million yen, Item Loss on liquidation of subsidiary / Amount 24 million yen |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name None / Excluded Number of companies 2 / Company name 艾恩伊（上海）化粧品有限公司, 株式会社Ｅｎｄｅａｖｏｕｒ |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 17,791,270 |
| Treasury Shares at Period-End | 241 |
| Factors Behind Changes in Business Performance | In the domestic business, strong performance by new products and the health food brand, together with the launch of new product lines, contributed to higher net sales. In the overseas business, the company promoted expansion into new markets, including the launch of BOTANIST at Costco in the United States and YOLU at OLIVE YOUNG in South Korea. All categories, including hair care, beauty appliances and skin care, recorded double-digit year-on-year growth. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the domestic business, new products such as the “Face Current Pointer,” the health food brand and the launch of new product lines contributed to higher net sales. In the overseas business, the company promoted expansion into new markets, including the launch of BOTANIST at Costco in the United States and YOLU at OLIVE YOUNG in South Korea. The company stated that it was difficult to estimate with certainty the impact of flexible investment during the second half, geopolitical risks surrounding the Strait of Hormuz and foreign exchange conditions, and therefore disclosed its full-year forecasts as ranges.